Medtech startup EzeRx raises an undisclosed amount of seed funding
- ByStartupStory | June 4, 2022
EzeRx, a Bhubaneswar-based med-tech firm, has raised an unknown sum of seed funding from Mankind Pharma Limited promoters, including Sheetal Arora. The funds received will be utilised to expand its operations and marketing, as well as increase sales in different countries throughout India, Africa, and South-East Asia, as well as pursue worldwide certifications and increase R&D initiatives.
The alliance aims to boost healthcare infrastructure while also making more advanced screening technologies available across the country, with a more patient-centric approach. EzeRx has received funds from the Department of Science and Technology’s NIDHI Prayas programme, the Department of Biotechnology’s BIG programme, BIRAC, the SASACT Grant from MeiTy, and a starting grant from Indian Oil Corporation and Startup Odisha.
Sheetal Arora, the promoter and CEO of Mankind Pharma Limited said that EzeRx principally focuses on offering high accuracy screening solutions for common primary health-related issues that often go overlooked due to their passivity, using a hand-held device. It is the company’s opinion that gadgets such as EzeRx will alter people’s attitudes regarding healthcare in India.
EzeRx, founded in 2018 by Partha, Chaitali Roy, and Sudip Roy Chowdhry, is a simple, painless, and non-invasive screening solution for identifying primary health parameters such as liver, kidney, and lung ailments, blood glucose levels, and common problems such as anaemia in less than a minute without drawing blood from the human body.
Partha, EzeRx’s founder stated that the discovery of health issues is the first step in treating them. As a result, the firm has worked tirelessly to design and manufacture innovative medical equipment for the proper management of the curative and preventative health care environment. The money would assist our firm in establishing collaborations with healthcare providers in order to incorporate our solutions onto their platforms.
Follow Startup Story
Related Posts
